ZYNE
|Zynerba Pharmaceuticals Inc
NASDAQ
USD
|%
Current Price
Change
(%)
P/E Ratio
Dividend Yield
Market Cap
70.12M
Volume
Open
Previous Close
52-Week High
52-Week Low
About Zynerba Pharmaceuticals Inc
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharm...
Sector:Healthcare
Industry:Drug Manufacturers - Specialty & Generic
CEO:Mr. Armando Anido MBA
Employees:25
Headquarters:Devon, USA
Website:www.zynerba.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions